国际麻醉学与复苏杂志   2015, Issue (2): 5-5
    
鞘内注射KN93对神经病理性疼痛大鼠痛行为学的影响
刘廪1()
1.徐州医学院
Effect of intrathecal injection of KN93 on pain behaviors in rats with neuropathic pain
 全文:
摘要:

目的 观察鞘内注射钙/钙调蛋白依赖性蛋白激酶Ⅱ(Ca2+/calmodulin dependent protein kinase Ⅱ, CaMKⅡ)抑制剂KN93对腰背根神经节慢性压迫(chronic compression of dorsal root ganglion, CCD)大鼠神经病理性疼痛的影响。 方法 SD雄性大鼠48只,按随机数字表法分为3组:假手术组(S组,11只)、CCD模型组(C组,11只)、KN93组(K组,26只)。C组、K组制备CCD模型,S组仅暴露L5~6椎间隙。术后14 d S组和C组鞘内注射10%溶媒二甲基亚砜(dimethyl sulfoxide, DMSO)25 μl,K组鞘内注射溶于10%DMSO的KN93 50 μg/25 μl。各组在造模前1 d(t1),造模后4(t2)、7(t3)、10(t4)、14 d(t5)随机取8只大鼠检测热缩足反射潜伏期(paw withdrawal thermal latency, PWTL)和机械缩足反射阈值(paw withdrawal mechanical threshold, PWMT);并于鞘内注射DMSO或KN93后2(t6)、4(t7)、10(t8)、12(t9)、24 h(t10)时进行相同的行为学检测。各组于给药前以及K组的给药后各时间点(t6~t9)随机取3只大鼠处死并取脊髓腰膨大部分,采用Western blot方法检测CaMKⅡ蛋白表达水平。 结果 鞘内给药后t6~t9时点,K组PWTL[(14.7±1.6)、(18.6±1.8)、(21.2±2.5)、(15.3±2.0) s],PWMT[(12.0±1.0)、(15.4±1.4)、(17.5±1.7)、(14.9±1.6) g]比C组PWTL[(11.6±1.8)、(10.7±1.7)、(11.7±2.4)、(9.9±1.7) s],PWMT[(8.4±0.9)、(9.6±1.6)、(10.6±1.7)、(8.9±1.3) g]升高,差异有统计学意义(P<0.05)。给药前及给药后t10时,K组PWTL、PWMT与C组比较,差异无统计学意义(P>0.05)。和t5时CaMKⅡ值(1.55±0.12)比较,给药后t6~t9时间点CaMKⅡ蛋白[(1.37±0.11),(1.15±0.12)、(0.75±0.08)、(0.86±0.12)]表达下降(P<0.05)。 结论 鞘内注射KN93可有效缓解神经病理性疼痛大鼠的疼痛反应。

关键词: KN93; 钙/钙调蛋白依赖性激酶Ⅱ; 腰背根神经节慢性压迫; 神经病理性疼痛;
Abstract:

Objective To investigate the effect of KN93, an inhibitor of Ca2+/calmodulin dependent protein kinase Ⅱ(CaMKⅡ), on the neuropathic pain of the chronic compression of dorsal root ganglion(CCD) model rats. Methods Forty-eight male SD rats were randomly divided into 3 groups: sham group (group S, n=11), CCD model group (group C, n=11), KN93 group (group K, n=26) . Group C and group K were operated with the model of neuropathic pain induced by CCD, group S were treated as sham operated rats. Fourteen days after operation, group S and group C received intrathecal injection of 10% dimethyl sulfoxide(DMSO) 25 μl, while group K received intrathecal injection of 50 μg KN93 dissolved in 25 μl 10% DMSO. Pain behavior tests including paw withdrawal thermal latency(PWTL) and paw withdrawal mechanical threshold(PWMT) were detected on eight rats randomly selected from each group before(t1) and 4(t2), 7(t3), 10(t4), 14 d(t5) after operation. Group S, group C and group K also received the same tests 2(t6), 4(t7), 10(t8), 12(t9), 24 h(10) after administration of DMSO or KN93. In all three groups before administration and in group K after administration at each time point(t6-t9), 3 randomly selected rats were sacrificed and each expansion part of spinal cord was obtained. Western blot was used to detect the expression level of CaMKⅡ protein. Results From t6 to t9 after administration, group K PWTL[(14.7±1.6), (18.6±1.8), (21.2±2.5), (15.3±2.0) s] and PWMT[(12.0±1.0),(15.4±1.4), (17.5±1.7), (14.9±1.6) g] were increased when compared with group C PWTL[(11.6±1.8), (10.7±1.7), (11.7±2.4),(9.9±1.7) s] and PWMT[(8.4±0.9), (9.6±1.6), (10.6±1.7), (8.9±1.3) g](P<0.05). Before and 24 h(t10) after administration, group K PWTL and PWMT had no significant difference when compared with group C(P>0.05). Compared to the basic value(t5)(1.55±0.12) prior to the administration, the expression of CaMKⅡ from t6 to t9[(1.37±0.11), (1.15±0.12), (0.75±0.08), (0.86±0.12)]were significantly decreased(P<0.05). Conclusions Intrathecal administration of KN93 may play an important role in relieving pain of neuropathic pain rats.

Key words: KN93; Ca2+/calmodulin dependent protein kinase Ⅱ; Chronic compression of dorsal root ganglion; Neuropathic pain; Rat